Metastasis Risk in Gleason Pattern 3 (Grade Group 1) Prostate Cancer
Gleason pattern 3 (Gleason score 3+3=6, now Grade Group 1) prostate cancer has essentially zero risk of metastasis over a five-year period, and even with long-term follow-up extending to decades, the metastatic potential remains negligible.
Evidence for Negligible Metastatic Risk
The most definitive evidence comes from a large single-institution study with extended follow-up that demonstrated zero metastases and zero disease-specific deaths among 449 patients with Gleason score ≤6 at radical prostatectomy, despite median follow-up of 100 months 1. This stands in stark contrast to higher grade disease where metastasis rates were 5.3% for Gleason 3+4=7,17% for Gleason 4+3=7, and 14% for Gleason 8-10 1.
The five-year metastasis-free survival for pure Gleason pattern 3 disease is 100% 2. Even when tertiary pattern 4 is present in otherwise Gleason 3+3=6 disease, the 5-year metastasis-free survival remains 100%, though these patients show intermediate risk for biochemical progression 2.
Population-Level Data
In nationwide SEER database analysis of 21,960 patients with Gleason 3+3=6 cancer who underwent radical prostatectomy with lymph node examination, the prevalence of nodal metastases was only 0.48% 3. This slightly higher rate in community practice compared to academic centers likely reflects inconsistent adherence to the 2005 ISUP Gleason grading criteria, where pattern 4 features may be misclassified as pattern 3 3.
Long-Term Outcomes
With ultra-long-term follow-up extending to 25-35 years, Gleason pattern 3 disease demonstrates remarkably indolent behavior 4. The 10-year risk of lethal disease (metastases or cancer-specific death) for Grade Group 2 (Gleason 3+4=7) is only 2%, and even by 25 years reaches only 5% 4. Pure Gleason pattern 3 disease performs even better than Grade Group 2, with essentially no metastatic events documented in properly classified cases.
Clinical Implications
The NCCN guidelines recognize this biology by stratifying Gleason 3+3=6 as low-risk disease, with active surveillance as the preferred management strategy for patients with life expectancy >10 years 5. The guidelines explicitly state that none of the current models predict metastasis with perfect accuracy, but those with Gleason score ≤6 have negligible metastatic potential 5.
Critical Caveat: Accurate Grading is Essential
The key pitfall is misclassification of Gleason pattern 4 as pattern 3. Following the 2005 ISUP consensus criteria, ill-defined glands with poorly formed lumina and large cribriform patterns must be classified as pattern 4, not pattern 3 6, 7. When these criteria are strictly applied by experienced genitourinary pathologists, true Gleason 3+3=6 disease shows no metastatic potential 1.
Patients with cribriform or intraductal histology should be excluded from low-risk classification and active surveillance protocols 8. These architectural patterns indicate higher-grade disease regardless of apparent Gleason pattern 3 cytology.
Practical Answer
For properly classified Gleason pattern 3 prostate cancer:
- Five-year metastasis probability: 0%
- Ten-year metastasis probability: 0%
- Long-term (>20 years) metastasis probability: <1% (likely representing misclassified cases)
The rare cases of apparent metastasis in Gleason 3+3=6 disease almost certainly represent either sampling error on biopsy (missing higher-grade components) or misapplication of grading criteria 1, 3.